Idexx Laboratories Inc(IDXX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | NDX, S&P 500 | P/E | 39.39 | EPS (ttm) | 14.23 | Insider Own | 0.38% | Shs Outstand | 78.9M | Perf Week | - |
| Market Cap | 44.15B | Forward P/E | 33.4 | EPS next Y | 13.56% | Insider Trans | -0.73% | Shs Float | 78.5M | Perf Month | 9.15% |
| Enterprise Value | 45.05B | PEG | 2.5 | EPS next Q | 3.72 | Inst Own | 97.33% | Short Float | 2.47% | Perf Quarter | 0.75% |
| Income | 1.14B | P/S | 9.7 | EPS this Y | 12.94% | Inst Trans | 0.55% | Short Ratio | 3.56 | Perf Half Y | -0.98% |
| Sales | 4.55B | P/B | 27.41 | EPS next 5Y | 13.35% | ROA | 33.65% | Short Interest | 1.94M | Perf YTD | -17.17% |
| Book/sh | 20.44 | P/C | 224.18 | EPS past 3/5Y | 17.66% 14.28% | ROE | 74.21% | 52W High | -27.22% ($769.98) | Perf Year | -12.25% |
| Cash/sh | 2.5 | P/FCF | 35.3 | Sales past 3/5Y | 8.52% 9.72% | ROIC | 56.62% | 52W Low | 11.94% ($500.61) | Perf 3Y | 31.02% |
| Dividend Est. | - | EV/EBITDA | 27.86 | EPS Y/Y TTM | 18.22% | Gross Margin | 62.53% | Volatility(W/M) | 1.96% 2.27% | Perf 5Y | -14.03% |
| Dividend TTM | - | EV/Sales | 9.89 | Sales Y/Y TTM | 12.77% | Oper. Margin | 32.12% | ATR (14) | 13.01 | Perf 10Y | 407.22% |
| Dividend Ex-Date | - | Quick Ratio | 0.81 | EPS Q/Q | 17.55% | Profit Margin | 25.03% | RSI (14) | 61.92 | Recom | 1.94 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.11 | Sales Q/Q | 9.66% | SMA20 | 4.98% ($533.8) | Beta | 1.55 | Target Price | $718.73 |
| Payout | - | Debt/Eq | 0.68 | Earnings | 2026/11/2 | SMA50 | 5.14% ($532.98) | Rel Volume | 0.73 | Prev Close | $566.76 |
| Employees | 11000 | LT Debt/Eq | 0.25 | EPS/Sales Surpr. | 8.28% 1.36% | SMA200 | -2.78% ($576.4) | Avg Volume(3M) | 0.55M | Price | $560.38 |
| IPO | 1991/6/21 | Option/Short | Yes/Yes | Trades | 12855 | Volume | 398,279 | Change | -1.13% |
🐾 A leading company in the global animal health diagnostics group, supplying diagnostic, testing, and software solutions for animals. Founded in 1983 and headquartered in Maine, USA, it operates an integrated business spanning companion animal, livestock, food, and water diagnostics, supplying diagnostic equipment, reagents, laboratory services, and software to animal hospitals and farms worldwide, making it a flagship company in the animal diagnostics group.
Over the past 1 year, on the lower side
27% below its 1-year high.
Traded less than usual. That is 73% of its average volume.
Next earnings report: November 2
7 days to go.
IDXX makes money exceptionally well
Of every $100 in sales, $32.12 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +12.9% this year.
Tap to view numbers
The price is about the industry average
For a company earning $100 a year, you would pay $3,939. Peers typically go for $3,633. Compared with its own 5-year average, it is 19% cheaper now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -14.0%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 97.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #7 of 44 in the industry
Based on market cap of $44B.
A#4 Agilent Technologies Inc $49B PER 34.1 
IQV#5 IQVIA Holdings Inc $46B PER 34.6 
WAT#6 Waters Corp $45B PER 113.3 
IDXX#7 Idexx Laboratories Inc $44B PER 39.4 
ILMN#8 Illumina Inc $41B PER 50.2 
FAQ
What kind of company is IDXX?
IDXX belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of IDXX?
The market cap of IDXX is approximately $44.1B, ranking 355 within its sector.
What is the P/E ratio of IDXX?
IDXX has a P/E ratio of approximately 39.4x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for IDXX?
IDXX has recorded a 52-week high of $769.98 and a low of $500.61.
